BRIEF-Luye Pharma Says NDA For Risperidone Extended-Release Microspheres For Injection Accepted

Nov 26 (Reuters) - Luye Pharma Group Ltd:

* LUYE PHARMA GROUP LTD - NEW DRUG APPLICATION FOR RISPERIDONE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY03004) HAS BEEN ACCEPTED BY CDE, NMPA Source text for Eikon: Further company coverage: